Compliance & Validation — Not documented by Atlas
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
Health technology company, profiled here for Zelta, its cloud clinical data management suite with AI-assisted study design tooling.
Merative, formed in 2022 when Francisco Partners acquired IBM Watson Health and headquartered in Ann Arbor, Michigan, is a standalone private-equity-owned health technology company. This profile focuses on Zelta, its clinical trial solutions business: a unified cloud platform spanning EDC, eCOA, RTSM, and eConsent with AI-assisted study design and data review features, which the company reports is used by more than 280 CROs and biopharma organizations. No public third-party security certification documentation for Zelta was identified at profiling time, so request compliance evidence directly during evaluation.
50% — Partial coverage. Coverage score — how completely Atlas documents Merative across 7 buyer-evaluation areas. Reflects available Atlas data, not solution quality.
Ask the vendor: Which compliance certifications (HIPAA, 21 CFR Part 11, SOC 2, GxP) do you hold?
cloud
Ask the vendor: What is your pricing model, and what drives total cost of ownership?
Ask the vendor: What is a realistic implementation timeline, and what onboarding support is included?
Mid-Size Biotech, Large Pharma, Top 20 Pharma, CRO / CDMO, Data Management, Clinical Operations
Clinical Data Management
Private equity, Founded 2022
Not captured in Atlas data — confirm directly. Excluded from the score above.
Who owns model outputs? Is our proprietary data used to train models others can access, and where does our data reside?
Can you share validation studies or benchmarks, explain how the model reaches its conclusions, and describe how bias and drift are monitored?